ATOROLIMUMAB
UNII ZT2TX7WZL7

Substance Identification & Data

This profile provides standardized clinical and technical data for Atorolimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZT2TX7WZL7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 202833-08-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ZT2TX7WZL7
CAS Registry Number
202833-08-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ATOROLIMUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C188669
National Cancer Institute reference terminology for clinical and research data.
INN ID
7647
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atorolimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ATOROLIMUMAB

Common Names & Synonyms

ATOROLIMUMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G3, ANTI-(HUMAN RH(D) ANTIGEN) (HUMAN MONOCLONAL CLONEP3X22914G4 .GAMMA.3-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CLONEP3X22914G4 .KAPPA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus